Literature DB >> 2531789

Prediction of successful primary closure of congenital abdominal wall defects using intraoperative measurements.

M Yaster1, T L Scherer, M M Stone, L G Maxwell, C L Schleien, R C Wetzel, J R Buck, D G Nichols, P M Colombani, D L Dudgeon.   

Abstract

To determine whether intragastric pressure (IGP) and central venous pressure (CVP) would reliably predict successful primary closure of congenital abdominal wall defects (omphalocele/gastroschisis) in newborn infants, we developed the following prospective intraoperative management protocol. Following a temporary trial of fascial closure, infants who had an IGP less than 20 mm Hg or an increase in CVP of less than 4 mm Hg were primarily closed. If IGP was greater than 20 mm Hg or if CVP increased by more than 4 mm Hg, the temporary closure of the abdomen was reopened and a prosthetic silo was placed. Ten infants who were less than 24 hours old and averaged 2.7 kg (range, 1.4 to 4.2 kg) and 37-weeks gestation (range, 32 to 41 weeks) were studied. Eight infants met criteria for primary closure. Their IGP averaged 14 +/- 4 mm Hg (+/- SD) (range, 8 to 19 mm Hg), and their increase in CVP averaged 1 +/- 2 mm Hg (range, -2 to 3 mm Hg). In the two infants who required staged repair, IGP averaged 25 +/- 1 mm Hg (+/- SD) (range, 24 to 25 mm Hg), and the increase in CVP averaged 7 +/- 1 mm Hg (range, 6 to 8 mm Hg). All patients were anesthetized with fentanyl (12.5 micrograms/kg) and paralyzed with metocurine (0.3 mg/kg) intraoperatively. There were no postoperative complications in either group of patients related to increased intraabdominal pressure, and all patients were extubated within 48 hours of the initial surgery. We conclude that the intraoperative measurement of changes in IGP and CVP can serve as a guide to the operative management of congenital abdominal wall defects and can reliably predict successful outcome following repair.

Entities:  

Mesh:

Year:  1989        PMID: 2531789     DOI: 10.1016/s0022-3468(89)80554-8

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  8 in total

1.  The outcome of newborns with abdominal wall defects according to the method of abdominal closure: the experience of a single center.

Authors:  João Gilberto Maksoud-Filho; Uenis Tannuri; Marcos Marques da Silva; João Gilberto Maksoud
Journal:  Pediatr Surg Int       Date:  2006-05-12       Impact factor: 1.827

2.  Intraoperative vascular assessment for estimation of risk in primary closure of omphalocele and gastroschisis.

Authors:  G Pistor; S Märzheuser-Brands; G Weber; R Streich
Journal:  Pediatr Surg Int       Date:  1996-03       Impact factor: 1.827

3.  The pivotal role of the surgeon in the results achieved in gastroschisis.

Authors:  M R Davies; P G Beale
Journal:  Pediatr Surg Int       Date:  1996-03       Impact factor: 1.827

Review 4.  Pain management in the critically ill child.

Authors:  M Yaster; D G Nichols
Journal:  Indian J Pediatr       Date:  2001-08       Impact factor: 1.967

5.  Comparison of indirect methods of measuring intra-abdominal pressure in children.

Authors:  Peter J Davis; Satajyit Koottayi; Anna Taylor; Warwick W Butt
Journal:  Intensive Care Med       Date:  2005-01-28       Impact factor: 17.440

6.  Controversies in the management of gastroschisis: a study of 40 patients.

Authors:  M D Stringer; R J Brereton; V M Wright
Journal:  Arch Dis Child       Date:  1991-01       Impact factor: 3.791

7.  Evolution of staged versus primary closure of gastroschisis.

Authors:  Joseph N Kidd; Richard J Jackson; Samuel D Smith; Charles W Wagner
Journal:  Ann Surg       Date:  2003-06       Impact factor: 12.969

8.  Recognition and management of abdominal compartment syndrome among German pediatric intensivists: results of a national survey.

Authors:  Torsten Kaussen; Gerd Steinau; Pramod Kadaba Srinivasan; Jens Otto; Michael Sasse; Franz Staudt; Alexander Schachtrupp
Journal:  Ann Intensive Care       Date:  2012-07-05       Impact factor: 6.925

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.